(Q85448625)
Statements
Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study (English)
Giorgio Vittorio Scagliotti
Vera Hirsh
David H Henry
Christian Manegold
Philippe Solal-Celigny
Gladys Rodriguez
Nilesh D Mehta
Lara Lipton
José Rodrigues Pereira
Kumar Prabhash
Tudor-Eliade Ciuleanu
Vladimir Kanarev
Huei Wang
Arun Balakumaran
1 December 2012